Your browser doesn't support javascript.
loading
Human mesenchymal stromal cells deliver systemic oncolytic measles virus to treat acute lymphoblastic leukemia in the presence of humoral immunity.
Castleton, Anna; Dey, Aditi; Beaton, Brendan; Patel, Bella; Aucher, Anne; Davis, Daniel M; Fielding, Adele K.
Affiliation
  • Castleton A; Department of Hematology, University College London, London, United Kingdom;
Blood ; 123(9): 1327-35, 2014 Feb 27.
Article in En | MEDLINE | ID: mdl-24345754
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oncolytic Viruses / Oncolytic Virotherapy / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Immunity, Humoral / Mesenchymal Stem Cells / Measles virus Limits: Adult / Animals / Humans Language: En Journal: Blood Year: 2014 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oncolytic Viruses / Oncolytic Virotherapy / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Immunity, Humoral / Mesenchymal Stem Cells / Measles virus Limits: Adult / Animals / Humans Language: En Journal: Blood Year: 2014 Document type: Article Country of publication: Estados Unidos